Indo Euro Indchem (BSE 524458)₹8.10+0.37%Specialty Chemicals
In the Mar 2026 quarter (standalone), Indo Euro Indchem reported sales of ₹8.14 Cr, up 112.5% from Mar 2025, and net profit of ₹0.07 Cr. For the year to Mar 2026, sales were ₹13.76 Cr and net profit ₹0.33 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1.44 | 0.98 | 1.02 | 7.43 | 4.94 | 0.92 | 4.24 | 3.83 | 1.55 | 2.82 | 1.27 | 8.14 |
| Expenses | 1.42 | 1.35 | 0.99 | 7.56 | 4.74 | 1.06 | 4.04 | 4.14 | 1.42 | 2.82 | 1.34 | 8.07 |
| Operating Profit | 0.00 | −0.38 | 0.00 | −0.17 | 0.16 | −0.15 | 0.17 | −0.33 | 0.10 | −0.01 | −0.08 | 0.01 |
| OPM % | 0.0% | −40.2% | 1.0% | −2.4% | 3.5% | −17.6% | 4.3% | −8.9% | 7.2% | −0.7% | −7.1% | 0.3% |
| Other Income | 0.10 | 0.43 | 0.09 | 0.24 | 0.15 | 0.21 | 0.14 | 0.16 | 0.16 | 0.16 | 0.12 | 0.13 |
| Interest | 0.00 | 0.00 | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 |
| Depreciation | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.05 | 0.00 | 0.00 | 0.02 |
| Profit before tax | 0.06 | 0.00 | 0.00 | 0.03 | 0.28 | 0.01 | 0.28 | −0.20 | 0.19 | 0.11 | 0.01 | 0.07 |
| Tax % | 28.6% | 500.0% | — | 50.0% | 27.6% | 50.0% | 27.6% | −61.9% | 25.0% | 25.0% | 0.0% | 25.0% |
| Net Profit | 0.06 | −0.05 | 0.02 | 0.03 | 0.23 | 0.02 | 0.22 | −0.09 | 0.16 | 0.10 | 0.02 | 0.07 |
| EPS (Rs) | 0.05 | −0.03 | 0.00 | 0.01 | 0.23 | 0.00 | 0.24 | −0.08 | 0.18 | 0.09 | 0.02 | 0.08 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5.54 | 3.10 | 7.67 | 0.82 | 6.36 | 7.63 | 22.69 | 10.10 | 10.85 | 13.93 | 13.76 | 13.78 |
| Expenses | 5.56 | 3.19 | 7.75 | 1.05 | 6.53 | 7.84 | 21.98 | 10.15 | 11.14 | 13.60 | 13.71 | 13.65 |
| Operating Profit | −0.04 | −0.10 | −0.11 | −0.24 | −0.20 | −0.25 | 0.56 | −0.10 | −0.35 | 0.23 | −0.02 | 0.02 |
| OPM % | −0.9% | −3.6% | −1.6% | −30.8% | −3.3% | −3.4% | 2.5% | −1.1% | −3.3% | 1.7% | −0.2% | 0.2% |
| Other Income | 0.07 | 0.29 | 0.32 | 0.39 | 0.34 | 0.44 | 0.25 | 0.50 | 0.62 | 0.23 | 0.53 | 0.57 |
| Interest | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.06 | 0.00 | 0.02 | 0.02 |
| Depreciation | 0.05 | 0.06 | 0.04 | 0.04 | 0.05 | 0.06 | 0.06 | 0.06 | 0.05 | 0.06 | 0.04 | 0.07 |
| Profit before tax | −0.06 | 0.09 | 0.13 | 0.06 | 0.04 | 0.08 | 0.71 | 0.28 | 0.11 | 0.38 | 0.40 | 0.38 |
| Tax % | −14.3% | 20.0% | 50.0% | 28.5% | 20.0% | 33.3% | 29.2% | 27.6% | 75.0% | 7.7% | 24.4% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | −0.06 | 0.09 | 0.09 | 0.06 | 0.04 | 0.08 | 0.52 | 0.23 | 0.05 | 0.37 | 0.33 | 0.35 |
| EPS (Rs) | −0.07 | 0.08 | 0.08 | 0.07 | 0.04 | 0.09 | 0.55 | 0.23 | 0.03 | 0.39 | 0.36 | 0.37 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 8.99 | 9.00 | 9.00 | 9.00 | 9.00 | 9.00 | 8.99 | 9.00 | 8.99 | 9.00 | 8.99 | 9.00 |
| Reserves | 1.01 | 0.96 | 1.08 | 1.14 | 0.52 | 0.56 | 0.63 | 1.15 | 1.24 | 1.65 | 2.40 | 2.72 |
| Borrowings | 0.44 | 0.00 | 0.00 | 0.00 | 0.00 | 0.11 | 0.09 | 0.07 | 0.03 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.47 | 0.58 | 0.44 | 3.70 | 1.00 | 6.08 | 7.28 | 6.28 | 4.77 | 5.61 | 8.05 | 7.85 |
| Total Liabilities | 10.91 | 10.54 | 10.52 | 13.84 | 10.52 | 15.75 | 16.99 | 16.50 | 15.03 | 16.26 | 19.44 | 19.57 |
| Fixed Assets | 0.75 | 0.65 | 0.58 | 0.42 | 0.37 | 0.47 | 0.40 | 0.34 | 0.28 | 0.22 | 0.17 | 1.02 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.22 | 0.73 | 1.68 | 0.73 |
| Investments | 0.47 | 0.47 | 0.51 | 0.49 | 0.27 | 0.28 | 0.28 | 0.28 | 0.16 | 0.08 | 0.00 | 0.00 |
| Other Assets | 9.69 | 9.42 | 9.43 | 12.93 | 9.88 | 15.00 | 16.31 | 15.88 | 14.37 | 15.23 | 17.59 | 17.82 |
| Inventories | 1.70 | 1.65 | 1.11 | 1.27 | 1.00 | 3.34 | 3.72 | 3.31 | 1.67 | 3.40 | 0.92 | 2.33 |
| Trade receivables | 3.07 | 4.67 | 3.22 | 5.46 | 2.34 | 4.11 | 5.67 | 8.18 | 7.58 | 8.62 | 13.90 | 3.06 |
| Cash & equivalents | 1.22 | 0.29 | 0.24 | 0.12 | 0.02 | 0.07 | 0.15 | 0.40 | 0.09 | 0.09 | 0.15 | 0.04 |
| Total Assets | 10.91 | 10.54 | 10.52 | 13.84 | 10.52 | 15.75 | 16.99 | 16.50 | 15.03 | 16.26 | 19.44 | 19.57 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | −2.38 | −1.55 | 2.40 | 0.29 | 0.28 | 0.58 | −1.21 | −1.79 | −2.37 | 0.58 | 0.39 | 9.08 |
| Cash from investing activity | 3.50 | 0.64 | −2.72 | 0.04 | 0.00 | −0.17 | 0.00 | 2.04 | 2.08 | −0.56 | −0.33 | −9.14 |
| Cash from financing activity | 0.00 | −0.03 | 0.29 | −0.43 | −0.38 | −0.38 | 1.29 | 0.00 | −0.03 | −0.02 | 0.00 | 0.00 |
| Net cash flow | 1.11 | −0.92 | −0.04 | −0.11 | −0.09 | 0.03 | 0.07 | 0.24 | −0.30 | 0.00 | 0.05 | −0.07 |
| Capex | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.17 | 0.00 | 0.00 | 0.25 | 0.52 | 0.97 | 0.00 |
| Free cash flow | −2.28 | −1.55 | 2.40 | 0.32 | 0.28 | 0.42 | −1.21 | −1.79 | −2.61 | 0.07 | −0.59 | 9.14 |
| CFO / OP % | 7,567.0% | 3,020.0% | −2,218.0% | −283.0% | −144.0% | −276.0% | 450.0% | −305.0% | 1,891.0% | −194.0% | 138.0% | −30,667.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 397 | 308 | 379 | 260 | 1,050 | 236 | 271 | 131 | 274 | 290 | 364 | 81 |
| Inventory days | 238 | 111 | 141 | 68 | 488 | 202 | 239 | 66 | 72 | 165 | 33 | 87 |
| Days payable | 38 | 24 | 31 | 165 | 265 | 359 | 462 | 116 | 201 | 259 | 280 | 265 |
| Cash conversion cycle | 595 | 392 | 487 | 161 | 1,271 | 77 | 46 | 80 | 143 | 195 | 116 | −98 |
| Working capital days | 526 | 392 | 482 | 161 | 1,236 | 113 | 107 | 85 | 275 | 236 | 184 | −60 |
| ROCE % | −0.4% | −0.5% | 1.0% | 2.3% | 0.8% | 0.6% | 1.0% | 7.4% | 3.0% | 3.8% | 7.0% | 3.8% |
For the Mar 2026 quarter, Indo Euro Indchem reported sales of ₹8.14 Cr, up 112.5% year on year and net profit of ₹0.07 Cr. The operating margin was 0.3%.
Indo Euro Indchem's sales for the year to Mar 2026 were ₹13.76 Cr; over the last twelve months they were ₹13.78 Cr.
Net profit for the year to Mar 2026 was ₹0.33 Cr, and ₹0.35 Cr over the last twelve months. Earnings per share over the same trailing period were ₹0.37.
Indo Euro Indchem reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹0.04 Cr.
Cash from operations was ₹9.08 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹9.14 Cr.